Walkner Condon Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Walkner Condon Financial Advisors's ABBV Position: Q2 2026 in Review
Walkner Condon Financial Advisors increased its AbbVie (ABBV) stake by 8.6% in Q2 2026, buying an estimated $47.8K and bringing the position to 2,816 shares worth $709K. The position accounts for 0.08% of the portfolio, ranked #157.
Walkner Condon Financial Advisors first reported a position in ABBV in Q1 2022 and has held it in 18 quarters since. The position peaked at $736K in Q4 2025. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Walkner Condon Financial Advisors held 2,816 shares of AbbVie worth $709K as of Q2 2026.
- Walkner Condon Financial Advisors bought 222 AbbVie shares in Q2 2026, an estimated $47.8K.
- AbbVie made up 0.08% of Walkner Condon Financial Advisors's portfolio in Q2 2026, its #157 holding.
- Walkner Condon Financial Advisors first reported a position in AbbVie in Q1 2022 and has held it in 18 quarters since.
- Walkner Condon Financial Advisors's AbbVie position peaked at $736K in Q4 2025.
- 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Walkner Condon Financial Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.